Response to: Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”

Response to: Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”

Saved in:

Bibliographic Details
Main Authors:	Peng Yuan, Yeben Qian, Peng Chen
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2016/5210902
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
by: Dong-Mei Zhu, et al.
Published: (2020-01-01)

A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma
by: Jun Wang, et al.
Published: (2013-01-01)

Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01)

Targeted Therapy in Hepatocellular Carcinoma
by: Clarinda W. L. Chua, et al.
Published: (2011-01-01)

Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01)

The Role of Bridging Therapy in Hepatocellular Carcinoma
by: Roberto Galuppo, et al.
Published: (2013-01-01)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01)

Emerging nanomedicine strategies for hepatocellular carcinoma therapy
by: Chen Guo, et al.
Published: (2024-09-01)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
by: Hui Ma, et al.
Published: (2021-01-01)

Machine Learning-based Prediction of HBV-related Hepatocellular Carcinoma and Detection of Key Candidate Biomarkers
by: Zeynep KUCUKAKCALI, et al.
Published: (2022-09-01)

The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
by: Yu ZC, et al.
Published: (2025-01-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Comment on “Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma”
by: Xu Wang, MD, et al.
Published: (2024-06-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)

Recent updates of centromere proteins in hepatocellular carcinoma: a review
by: Zhongyuan Yang, et al.
Published: (2025-02-01)

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01)

Dramatic Reduction in Tumour Size in Hepatocellular Carcinoma Patients on Thalidomide Therapy
by: Denny Demeria, et al.
Published: (2007-01-01)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
by: Akihiro Tamori, et al.
Published: (2016-01-01)

Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy
by: Min Guo, et al.
Published: (2022-01-01)

Complete remission in an advanced hepatocellular carcinoma patient with AXIN1 mutation after systemic therapy: A case report
by: Yihong Ran, et al.
Published: (2025-01-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Real world study on combining local interventions with systemic therapy in unresectable hepatocellular carcinoma
by: Zhaosong Xue, et al.
Published: (2025-02-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success
by: Curtis L Cooper
Published: (2010-01-01)

Towards Curative Therapy in Burkitt Lymphoma: The Role of Early African Studies in Demonstrating the Value of Combination Therapy and CNS Prophylaxis
by: Ian Magrath
Published: (2012-01-01)

Hepatocellular Carcinoma Metastasis to the Orbit in a Coinfected HIV+ HBV+ Patient Previously Treated with Orthotopic Liver Transplantation: A Case Report
by: S. Guerriero, et al.
Published: (2011-01-01)

Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.
by: Lei Yang, et al.
Published: (2025-01-01)

Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
by: Yu-zhe Cao, et al.
Published: (2024-11-01)

A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
by: Erin N. Bodine, et al.
Published: (2017-07-01)

Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-Analysis
by: Meng Hsuan Kuo, et al.
Published: (2024-12-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
by: Teresa Urraro, et al.
Published: (2015-01-01)

Epidemiology of Hepatocellular Carcinoma
by: Mimi C Yu, et al.
Published: (2000-01-01)

RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-06-01)

A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
by: Yikai Wang, et al.
Published: (2022-01-01)

Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
by: Biling Gan, et al.
Published: (2025-02-01)

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo
by: Song He, et al.
Published: (2013-01-01)

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival
by: Jared R. Robbins, et al.
Published: (2019-03-01)

Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
by: Atsushi Naganuma, et al.
Published: (2025-01-01)